Battle for HIV drug market share getting fiercer - maybe too fierce for some
26-Sep-2008 -
The HIV market, worth $9.3 billion in 2007, is expected to grow to $15.1 billion by 2017, driven by the increasing prevalence of HIV worldwide and the longer life expectancy of patients receiving treatment. Despite this growth, the competition is getting tougher across all antiretroviral drug ...
acute myocardial infarction
BMS
Bristol-Myers Squibb
+10